on BIOSYNEX (EPA:ALBIO)
BIOSYNEX SA unveils its financial calendar for 2026
BIOSYNEX SA, a specialist in healthcare diagnostics, has published its 2026 financial calendar. The group, known for its rapid tests and expertise in molecular biology, has announced key dates for the coming year. Revenue for 2025 will be released on January 15, 2026, followed by the annual results on April 22. First-half revenue will be announced on July 22, and the first-half results are expected on October 21. These announcements will follow market close.
Founded in 2005, BIOSYNEX is recognized for its innovative solutions for laboratories, hospitals, and the general public. The group employs over 450 people and operates in 95 countries, maintaining a strong position on Euronext Growth Paris.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all BIOSYNEX news